Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
oral
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 1996 |
| gptkbp:ATCCode |
J05AG01
|
| gptkbp:availableOn |
gptkb:tablet
oral suspension |
| gptkbp:brand |
gptkb:nevirapine
|
| gptkbp:contraindication |
severe liver impairment
hypersensitivity to nevirapine |
| gptkbp:drugClass |
non-nucleoside reverse transcriptase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Viramune
|
| gptkbp:indication |
combination antiretroviral therapy
|
| gptkbp:interactsWith |
gptkb:rifampin
gptkb:ketoconazole oral contraceptives |
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:sideEffect |
fever
rash hepatotoxicity |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:nevirapine
|
| gptkbp:bfsLayer |
6
|